Life insurance

Type of contract

Follow Life insurance on Notably News to receive short updates to your email — rarely!

We include updates on Pradhan Mantri Jeevan Jyoti Bima Yojana, Double indemnity, Zillmerisation, New business strain, Value of in-force, Endowment policy, Lisenba v. California, Net premium valuation, Medical underwriting, Margin on services, Milton Rice Polland, Annual premium equivalent, Endowment selling, Golsen v. Commissioner, Nelson–Aalen estimator, Internal Revenue Code section 79 ... and more.

April 2025
Pradhan Mantri Jeevan Jyoti Bima Yojana
Total enrolments reached 23.6 crore under PMJJBY, 51 crore under PMSBY, and 7.6 crore under APY.
April 2025
Pradhan Mantri Jeevan Jyoti Bima Yojana
Reached over 23.6 crore enrolments under Pradhan Mantri Jeevan Jyoti Bima Yojana (PMJJBY), with total claims settled worth ₹18,398 crore for over 9 lakh families.
June 28 2023
Pradhan Mantri Jeevan Jyoti Bima Yojana
Claim settlement ratio reported as 99.94% for PMJJBY and 97.52% for PMSBY as of this date.
June 28 2023
Pradhan Mantri Jeevan Jyoti Bima Yojana
Insurance companies reported a claim settlement ratio of 99.94% for PMJJBY and 97.52% for Pradhan Mantri Suraksha Bima Yojana (PMSBY).
April 26 2023
Pradhan Mantri Jeevan Jyoti Bima Yojana
Total disbursed amount for insurance claims reached Rs. 13,290.40 crore, demonstrating the significant financial support provided to beneficiaries under the scheme.
2021
Pradhan Mantri Jeevan Jyoti Bima Yojana
News reports revealed the scheme's failure during the COVID-19 crisis, highlighting significant challenges in claim processing and policy implementation for the Pradhan Mantri Jeevan Jyoti Bima Yojana (PMJJBY).
2015
Pradhan Mantri Jeevan Jyoti Bima Yojana
Pradhan Mantri Jeevan Jyoti Bima Yojana (PMJJBY) was launched as a government-sponsored life insurance scheme to provide affordable life insurance coverage to Indian citizens.

This contents of the box above is based on material from the Wikipedia article Pradhan Mantri Jeevan Jyoti Bima Yojana, which is released under the Creative Commons Attribution-ShareAlike 4.0 International License.

See Also